AMN Healthcare Services (AMN)
(Delayed Data from NYSE)
$52.03 USD
+0.17 (0.33%)
Updated Aug 16, 2024 04:00 PM ET
After-Market: $52.04 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$52.03 USD
+0.17 (0.33%)
Updated Aug 16, 2024 04:00 PM ET
After-Market: $52.04 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
Zacks News
Baxter's (BAX) Theranova-Enabled HDx Therapy Data Positive
by Zacks Equity Research
Baxter's (BAX) Theranova-enabled HDx therapy is likely to boost clinical outcomes and lower healthcare resource utilization.
AMN Healthcare (AMN) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
AMN Healthcare (AMN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Why You Should Add Veeva Systems (VEEV) to Your Portfolio
by Zacks Equity Research
Investors continue to be optimistic about Veeva Systems (VEEV) on its slew of partnerships and robust product adoptions.
HealthEquity (HQY) Q1 Earnings Beat Estimates, FY22 View Up
by Zacks Equity Research
HealthEquity (HQY) delivers solid growth in HSAs along with recording robust Interchange revenues in the first quarter of fiscal 2022.
3 Reasons Growth Investors Will Love AMN Healthcare (AMN)
by Zacks Equity Research
AMN Healthcare (AMN) could produce exceptional returns because of its solid growth attributes.
Here's Why AMN Healthcare Services (AMN) is a Great Momentum Stock to Buy
by Zacks Equity Research
Does AMN Healthcare Services (AMN) have what it takes to be a top stock pick for momentum investors? Let's find out.
LHC Group (LHCG) Forays Into Oregon With New Acquisition
by Zacks Equity Research
LHC Group (LHCG) acquires Home 'n Hospice to expand its existing footprint in Idaho.
AMN Healthcare (AMN) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
AMN Healthcare (AMN) possesses solid growth attributes, which could help it handily outperform the market.
PerkinElmer (PKI) Boosts Cell Biology Portfolio With Buyout
by Zacks Equity Research
PerkinElmer (PKI) enters into an agreement to acquire Nexcelom that will enable the former to boost its efforts when it comes to solutions for drug discovery.
Earnings Estimates Rising for AMN Healthcare (AMN): Will It Gain?
by Zacks Equity Research
AMN Healthcare (AMN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
AMN Healthcare (AMN) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
AMN Healthcare (AMN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
AMN Healthcare (AMN) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
AMN Healthcare (AMN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
AMN Healthcare (AMN) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
AMN Healthcare (AMN) gains from segmental strength in the first quarter.
AMN Healthcare (AMN) Soars 5.6%: Is Further Upside Left in the Stock?
by Zacks Equity Research
AMN Healthcare (AMN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
AMN Healthcare Services (AMN) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
AMN Healthcare (AMN) delivered earnings and revenue surprises of 25.00% and 9.20%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
AMN Healthcare Services (AMN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
AMN Healthcare (AMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Analyst Blog Highlights: Pfizer, UnitedHealth Group, Centene Corp, Cigna Corp and AMN Healthcare Services
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Pfizer, UnitedHealth Group, Centene Corp, Cigna Corp and AMN Healthcare Services
4 Stocks That Continue to Gain From Telehealth Offerings
by Zacks Equity Research
We take a sneak peek into four telehealth stocks that are well-poised for growth on their robust digital services suite.
Why Is AMN Healthcare (AMN) Up 2.5% Since Last Earnings Report?
by Zacks Equity Research
AMN Healthcare (AMN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Retain AMN Healthcare (AMN) Stock Now
by Zacks Equity Research
Investor optimism is high on AMN Healthcare (AMN) stock, courtesy of its solid prospects.
Teladoc (TDOC) Q4 Loss Widens, Revenues Surpass Estimates
by Zacks Equity Research
Teladoc's (TDOC) Q4 earnings result reflects revenue gains, more than offset by flared-up expenses.
AMN Healthcare (AMN) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
AMN Healthcare (AMN) gains from the Nurse and Allied Solutions segment in the fourth quarter.
AMN Healthcare Services (AMN) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
AMN Healthcare (AMN) delivered earnings and revenue surprises of 12.36% and 0.90%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Can AMN Healthcare (AMN) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
AMN Healthcare (AMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here's Why You Should Retain AMN Healthcare (AMN) Stock Now
by Zacks Equity Research
AMN Healthcare (AMN) continues to gain traction from its wide range of services, and Healthcare MSP. Intense competition remains a woe.